Researchers develop improved expert system for diagnosis of thyroid disease

NewsGuard 100/100 Score

Researchers in India have developed an improved expert system for the diagnosis of thyroid disease. They describe details of their approach to screening medical data in a forthcoming issue of the International Journal of Computational Science and Engineering.

Thyroid disease in which either too much thyroid hormone is produced (hyperthyroidism) or too little is made (hypothyroidism) are common health problems across the globe. An overactive thyroid can lead to increased perspiration, a raise pulse, tremors, anxiety, nervousness, and irritability, insomnia, thinning of the skin, fine brittle hair, and muscular weakness. Sluggish thyroid in contrast might cause constipation, cold intolerance, decreased sweating, a slow pulse, depression, dry skin and poor female fertility. Thyroid disease is often asymptomatic and is commonly undiagnosed. It is obviously less of a clinical problem if there are no symptoms but left untreated symptoms can ultimately become apparent causing various problems for patients with either an overactive or a sluggish thyroid.

Jaganathan Palanichamy and Rajkumar Nallamuthu of the PSNA College of Engineering and Technology, in Tamilnadu, India, have descried that thyroid can effectively be diagnosed through proper and careful interpretation of the thyroid data but the classification of a raw dataset from patient records can also allow undiagnosed thyroid problems to be discovered through computerized screening.

The screening algorithm developed by the PSNA team boosts the accuracy of earlier approaches, bringing the level to almost 93.5%, as opposed to earlier tests that had 92% confidence or less. That means that 15 more patients are given neither a false positive nor a false negative of every 1000 in the screened dataset. Over a healthcare network with millions of patients that can amount to significant numbers of people correctly identified with a thyroid problem based on patient records rather than having to carry out specific thyroid function blood tests. As such, the screening approach could also be used by doctors in a clinical setting to assess patients that present with a range of symptoms and so identify with precision whether a thyroid test and subsequent pharmaceutical intervention is required.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Low-risk differentiated thyroid cancer patients in the U. S. experience lower rates of mortality